Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$2.72B |
| 2 |
Meta Platforms (Facebook)
META
|
+$660M |
| 3 |
Micron Technology
MU
|
+$605M |
| 4 |
Mastercard
MA
|
+$497M |
| 5 |
Tesla
TSLA
|
+$495M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.33B |
| 2 |
Visa
V
|
+$1.26B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 4 |
Lam Research
LRCX
|
+$699M |
| 5 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$681M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 79.37% |
| 2 | Technology | 4.49% |
| 3 | Healthcare | 2.99% |
| 4 | Financials | 2.85% |
| 5 | Industrials | 2.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
TRVG
12551
trivago
TRVG
$330M
| $27.5K | ﹤0.01% |
10,145
-32,479
| -76% | -$93K |
2016 Q4
37 quarters
|
|
12552
SemiLEDS
LEDS
$19.2M
| $27.5K | ﹤0.01% |
+21,969
| New | +$35.1K |
2026 Q1
0 quarters
|
|
12553
CALL
Loop Industries
LOOP
$21.7M
| $27.5K | ﹤0.01% |
19,200
-2,500
| -12% | -$3.13K |
2025 Q4
1 quarter
|
|
|
IMMP
12554
Immutep
IMMP
$32.1M
| $27.4K | ﹤0.01% |
+3,909
| New | +$179K |
2026 Q1
0 quarters
|
|
|
NAKA
12555
Nakamoto Inc
NAKA
$173M
| $27.3K | ﹤0.01% |
3,086
+1,207
| +64% | +$15.3K |
2025 Q3
2 quarters
|
|
12556
CALL
Ispire Technology
ISPR
$79.7M
| $27.2K | ﹤0.01% |
14,800
+600
| +4% | +$1.55K |
2023 Q4
9 quarters
|
|
|
FARM
12557
CALL
DELISTED
Farmer Brothers
FARM
| $27.2K | ﹤0.01% |
21,400
+10,100
| +89% | +$14.8K |
2025 Q4
1 quarter
|
|
12558
GT Biopharma
GTBP
$11M
| $27K | ﹤0.01% |
2,647
-583
| -18% | -$7.95K |
2025 Q3
2 quarters
|
|
12559
PUT
NET Power
NPWR
$123M
| $27K | ﹤0.01% |
17,300
-21,600
| -56% | -$46.1K |
2023 Q4
9 quarters
|
|
12560
PRF Technologies Ltd
PRFX
$3.22M
| $26.8K | ﹤0.01% |
+13,220
| New | +$42.2K |
2026 Q1
0 quarters
|
|
|
SLXN
12561
Silexion Therapeutics
SLXN
$1.45M
| $26.8K | ﹤0.01% |
2,093
+872
| +71% | +$15.3K |
2025 Q4
1 quarter
|
|
12562
PUT
OPAL Fuels
OPAL
$52.7M
| $26.7K | ﹤0.01% |
+10,600
| New | +$24.3K |
2026 Q1
0 quarters
|
|
|
UCL
12563
uCloudlink Group
UCL
$10.5M
| $26.4K | ﹤0.01% |
18,757
-16,090
| -46% | -$25.8K |
2025 Q3
2 quarters
|
|
|
VEEA
12564
Veea Inc
VEEA
$10.4M
| $26.4K | ﹤0.01% |
+2,478
| New | +$27.1K |
2026 Q1
0 quarters
|
|
12565
Arts-Way Manufacturing Co
ARTW
$16.3M
| $26.2K | ﹤0.01% |
12,545
-21,069
| -63% | -$49.4K |
2025 Q3
2 quarters
|
|
12566
CALL
Good Times Restaurants
GTIM
$15.8M
| $26.2K | ﹤0.01% |
22,400
-2,000
| -8% | -$2.39K |
2024 Q1
8 quarters
|
|
12567
PUT
Zentalis Pharmaceuticals
ZNTL
$239M
| $26.2K | ﹤0.01% |
+11,200
| New | +$28.9K |
2026 Q1
0 quarters
|
|
12568
CALL
Citius Pharmaceuticals
CTXR
$14.6M
| $26.2K | ﹤0.01% |
29,100
-38,000
| -57% | -$30.7K |
2024 Q2
7 quarters
|
|
12569
CALL
Veru
VERU
$42.8M
| $26.1K | ﹤0.01% |
+11,800
| New | +$28.7K |
2026 Q1
0 quarters
|
|
12570
Enlivex Ltd
ENLV
$7.71M
| $26K | ﹤0.01% |
1,864
+158
| +9% | +$2.5K |
2025 Q3
2 quarters
|
|
12571
PUT
Mammoth Energy Services
TUSK
$135M
| $26K | ﹤0.01% |
+10,600
| New | +$24.1K |
2026 Q1
0 quarters
|
|
|
CURX
12572
Curanex Pharmaceuticals
CURX
$7.4M
| $25.9K | ﹤0.01% |
2,528
-2,686
| -52% | -$20.2K |
2025 Q3
2 quarters
|
|
12573
Matinas BioPharma
MTNB
$2.59M
| $25.8K | ﹤0.01% |
3,447
-935
| -21% | -$8.78K |
2025 Q4
1 quarter
|
|
12574
Marchex
MCHX
$57.2M
| $25.8K | ﹤0.01% |
+16,629
| New | +$26.2K |
2026 Q1
0 quarters
|
|
12575
Wheels Up
UP
$127M
| $25.6K | ﹤0.01% |
2,478
-3,301
| -57% | -$43K |
2025 Q3
2 quarters
|
|
Similar funds
Citadel Advisors's Q1 2026 Portfolio in Review
As of Q1 2026, Citadel Advisors held 14,860 positions worth $618B, down 7.1% from $666B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Citadel Advisors's Q1 2026 filing shows 2,347 new, 5,138 increased, 5,286 reduced and 2,003 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 3,431,225 shares worth $327M. The largest sale was Amazon, an estimated $1.33B.
By sector, the portfolio is most concentrated in Miscellaneous at 79% of assets, down from 80% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q1 2026 buy was iShares 7-10 Year Treasury Bond ETF: 3,431,225 shares worth $327M.
- Citadel Advisors added most to iShares Core S&P 500 ETF in Q1 2026, an estimated $2.72B increase.
- Citadel Advisors's biggest Q1 2026 reduction was Amazon, cutting an estimated $1.33B.
- Citadel Advisors fully exited CyberArk in Q1 2026, selling an estimated $305M.
- Citadel Advisors's ten largest holdings make up 22% of its $618B portfolio in Q1 2026.
- Citadel Advisors opened 2,347 new positions and closed 2,003 in Q1 2026.
- Citadel Advisors's portfolio value fell 7.1% quarter-over-quarter to $618B.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.